Yang Sheng, Deputy Director of the State Drug Administration, attends a special work meeting on the high-quality development of traditional Chinese and ethnic medicines in the western region.

From December 2nd to 3rd, Yang Sheng, a member of the Party Group and Deputy Director of the National Medical Products Administration, attended a special work meeting on the high-quality development of traditional Chinese and ethnic medicine in the western region in Xining, Qinghai, and conducted research at ethnic medicine companies and Tibetan hospitals. Yang Sheng emphasized the need to thoroughly implement the spirit of the Fourth Plenary Session of the 20th Central Committee of the Communist Party of China, benchmarking the requirements of the "14th Five-Year Plan" with high-quality development as the theme and reform and innovation as the fundamental driving force, to form regional synergies, coordinate vertically and horizontally, accelerate the improvement of standards and norms for ethnic medicine, and strengthen the foundation for development. Furthermore, local advantages should be leveraged effectively, support policies should be utilized well, and innovation and transformation in the research and development of characteristic ethnic medicines and medical institution formulations should be promoted. It is important to adhere to coordinated development and safety, strengthen local supervision and regional coordination, and promote the high-quality development of the ethnic medicine industry to a new level.